Skip to content

Author

M. Abdelsayed

We have 2 of 36 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

FDA-Approved Drug Repurposing as p53 Mutants Rescue Candidates Using Structure-Based Virtual Screening and Molecular Simulations

This study presents a structure-based virtual screening and molecular dynamics approach to nominate FDA-approved drugs as candidate stabilizers of mutant p53 for downstream experimental validation and nominates DB09280 as a promising candidate structural stabilizer of mutant p53 worthy of experimental follow-up.

M. Abdelsayed, Y. Boulaamane · 0 citations
Open access Aug 2026

QSAR-Guided Virtual Screening and Molecular Dynamics Reveal Olaparib as a Repurposing Lead Against α-Synuclein Aggregation

These findings identify Olaparib as a novel high-affinity repurposing lead, while Paliperidone and Risperidone are reported as chemically informative secondary NAC–groove binders rather than proposed antiparkinsonian therapeutics, given that their dopamine D2-antagonist pharmacology is clinically associated with drug-i...

M. Abdelsayed, Y. Boulaamane · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.